用于治疗儿童肌张力障碍和痉挛的药物疗法概述。 - Suppr

Suppr

超能文献

An overview of drug therapies used in the treatment of dystonia and spasticity in children.

作者信息

Tickner Neil, Apps John R, Keady Simon, Sutcliffe Alastair G

机构信息

Department of Pharmacy, University College London Hospitals, London, UK.

出版信息

Arch Dis Child Educ Pract Ed. 2012 Dec;97(6):230-5. doi: 10.1136/archdischild-2011-301170. Epub 2012 Aug 15.

DOI:10.1136/archdischild-2011-301170

PMID:22896738

Abstract

摘要

相似文献

An overview of drug therapies used in the treatment of dystonia and spasticity in children.

Arch Dis Child Educ Pract Ed. 2012 Dec;97(6):230-5. doi: 10.1136/archdischild-2011-301170. Epub 2012 Aug 15.

Drug treatments for spasticity.

Ann Phys Rehabil Med. 2009 Dec;52(10):746-56. doi: 10.1016/j.rehab.2009.09.005. Epub 2009 Nov 4.

New approaches to managing spasticity in children with cerebral palsy.

West J Med. 1997 Apr;166(4):271.

Treatment of children with cerebral palsy.

J Pediatr Orthop B. 2007 Jul;16(4):303. doi: 10.1097/BPB.0b013e3280b077d7.

Management of spasticity in children with cerebral palsy.

Semin Pediatr Neurol. 2009 Jun;16(2):82-9. doi: 10.1016/j.spen.2009.03.006.

Chemodenervation with botulinum toxin for spasticity and dystonia. The effects on gait.

Adv Neurol. 2001;87:265-9.

[Spasticity in children cerebral palsy: diagnosis and treatment strategies].

Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(7 Pt 2):24-8.

[Management of spasticity in children with cerebral palsy].

Acta Orthop Traumatol Turc. 2009 Mar-Apr;43(2):81-6. doi: 10.3944/AOTT.2009.081.

Dantrolene: new indication. Cerebral palsy in children: uncertain clinical benefit.

Prescrire Int. 2008 Dec;17(98):237.

The role of intrathecal baclofen in the management of primary and secondary dystonia in children.

Br J Neurosurg. 2007 Aug;21(4):355-8. doi: 10.1080/02688690701392899.

引用本文的文献

Inhibitory Synaptic Influences on Developmental Motor Disorders.

Int J Mol Sci. 2023 Apr 9;24(8):6962. doi: 10.3390/ijms24086962.

Interventional Approaches to Pain and Spasticity Related to Cerebral Palsy.

Psychopharmacol Bull. 2020 Oct 15;50(4 Suppl 1):108-120.

Cerebral Palsy: An Overview.

Indian J Pediatr. 2018 Nov;85(11):1006-1016. doi: 10.1007/s12098-017-2475-1. Epub 2017 Nov 20.

Use of Disease-Modifying Therapies in Pediatric MS.

Curr Treat Options Neurol. 2016 Aug;18(8):36. doi: 10.1007/s11940-016-0420-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

An overview of drug therapies used in the treatment of dystonia and spasticity in children.

Arch Dis Child Educ Pract Ed. 2012 Dec;97(6):230-5. doi: 10.1136/archdischild-2011-301170. Epub 2012 Aug 15.

Drug treatments for spasticity.

Ann Phys Rehabil Med. 2009 Dec;52(10):746-56. doi: 10.1016/j.rehab.2009.09.005. Epub 2009 Nov 4.

New approaches to managing spasticity in children with cerebral palsy.

West J Med. 1997 Apr;166(4):271.

Treatment of children with cerebral palsy.

J Pediatr Orthop B. 2007 Jul;16(4):303. doi: 10.1097/BPB.0b013e3280b077d7.

Management of spasticity in children with cerebral palsy.

Semin Pediatr Neurol. 2009 Jun;16(2):82-9. doi: 10.1016/j.spen.2009.03.006.

Chemodenervation with botulinum toxin for spasticity and dystonia. The effects on gait.

Adv Neurol. 2001;87:265-9.

[Spasticity in children cerebral palsy: diagnosis and treatment strategies].

Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(7 Pt 2):24-8.

[Management of spasticity in children with cerebral palsy].

Acta Orthop Traumatol Turc. 2009 Mar-Apr;43(2):81-6. doi: 10.3944/AOTT.2009.081.

Dantrolene: new indication. Cerebral palsy in children: uncertain clinical benefit.

Prescrire Int. 2008 Dec;17(98):237.

The role of intrathecal baclofen in the management of primary and secondary dystonia in children.

Br J Neurosurg. 2007 Aug;21(4):355-8. doi: 10.1080/02688690701392899.

引用本文的文献

Inhibitory Synaptic Influences on Developmental Motor Disorders.

Int J Mol Sci. 2023 Apr 9;24(8):6962. doi: 10.3390/ijms24086962.

Interventional Approaches to Pain and Spasticity Related to Cerebral Palsy.

Psychopharmacol Bull. 2020 Oct 15;50(4 Suppl 1):108-120.

Cerebral Palsy: An Overview.

Indian J Pediatr. 2018 Nov;85(11):1006-1016. doi: 10.1007/s12098-017-2475-1. Epub 2017 Nov 20.

Use of Disease-Modifying Therapies in Pediatric MS.

Curr Treat Options Neurol. 2016 Aug;18(8):36. doi: 10.1007/s11940-016-0420-7.